Genialis

Genialis is a precision oncology company that develops AI foundation models of cancer biology to assist in drug development and clinical trials. The company provides multiomics and clinical data infrastructure to identify patient subgroups, predict drug resistance, and enhance patient stratification for pharmaceutical partners. Its products, such as krasID and adcID, are designed to de-risk global asset partnerships and improve the success rates of molecules in clinical trials.